We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
351
DELISTED
Pioneer Natural Resource Co.
PXD
$444M 0.04%
1,777,644
+51,168
+3% +$11.6M
CFLT
352
DELISTED
Confluent
CFLT
$438M 0.04%
10,688,776
+7,559,801
+242% +$394M
VMC icon
353
Vulcan Materials
VMC
$36.2B
$437M 0.04%
2,378,981
-1,228,705
-34% -$229M
BZ icon
354
Kanzhun
BZ
$6.84B
$436M 0.04%
17,519,406
+9,427
+0.1% +$274K
ACC
355
DELISTED
American Campus Communities, Inc.
ACC
$433M 0.04%
7,736,465
+459,099
+6% +$24.6M
BPOP icon
356
Popular Inc
BPOP
$11.3B
$431M 0.04%
5,275,354
+54,155
+1% +$4.78M
ALB icon
357
Albemarle
ALB
$15.5B
$430M 0.04%
1,945,291
+860,744
+79% +$182M
T icon
358
AT&T
T
$168B
$430M 0.04%
24,068,934
-6,408,129
-21% -$119M
PAYC icon
359
Paycom
PAYC
$9.72B
$427M 0.04%
1,232,243
-871,375
-41% -$292M
SG icon
360
Sweetgreen
SG
$705M
$420M 0.04%
13,543,968
+2,938,063
+28% +$85.3M
BRO icon
361
Brown & Brown
BRO
$23.8B
$417M 0.04%
5,774,998
+35,167
+0.6% +$2.36M
MRNA icon
362
Moderna
MRNA
$25.1B
$417M 0.04%
2,418,441
-13,367
-0.5% -$2.25M
NTRS icon
363
Northern Trust
NTRS
$34.8B
$414M 0.04%
3,557,061
+48,890
+1% +$5.8M
KMPR icon
364
Kemper
KMPR
$1.58B
$414M 0.04%
7,318,731
+400,863
+6% +$22.2M
NCNO icon
365
nCino
NCNO
$2.14B
$413M 0.04%
10,073,215
+399,781
+4% +$18.3M
RBC icon
366
RBC Bearings
RBC
$17.7B
$410M 0.04%
2,117,067
+429,073
+25% +$81.9M
PSB
367
DELISTED
PS Business Parks, Inc.
PSB
$402M 0.04%
2,394,239
+94,442
+4% +$15.6M
NBIX icon
368
Neurocrine Biosciences
NBIX
$15.4B
$402M 0.04%
4,288,770
-70,875
-2% -$6.01M
APLS
369
DELISTED
Apellis Pharmaceuticals
APLS
$401M 0.04%
7,884,839
+2,586,348
+49% +$114M
CGNX icon
370
Cognex
CGNX
$10.4B
$399M 0.04%
5,177,128
+1,898,715
+58% +$130M
ARE icon
371
Alexandria Real Estate Equities
ARE
$8.33B
$397M 0.04%
1,970,290
-1,358,325
-41% -$265M
AON icon
372
Aon
AON
$75.1B
$393M 0.04%
1,207,436
-24,937
-2% -$7.25M
PZZA icon
373
Papa John's
PZZA
$816M
$392M 0.04%
3,722,660
+96,240
+3% +$10.8M
OPEN icon
374
Opendoor
OPEN
$3.5B
$392M 0.04%
46,781,963
+9,406,670
+25% +$87.5M
WING icon
375
Wingstop
WING
$3.11B
$391M 0.04%
3,332,109
+1,267,890
+61% +$180M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.